Evidence map›Paper›PMID 33557396›Full record

ArticleInternational journal of molecular sciences2021

HIV-1 Tat Activates Akt/mTORC1 Pathway and AICDA Expression by Downregulating Its Transcriptional Inhibitors in B Cells.

Burkitkan Akbay, Diego Germini, Amangeldy K Bissenbaev, Yana R Musinova, Evgeny V Sheval, Yegor Vassetzky, Svetlana Dokudovskaya

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?Microbiology and molecular biology reviews : MMBR · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. mTOR Signaling Network in Cell Biology and Human Disease.International journal of molecular sciences · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Burkitkan AkbayCNRS UMR9018, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.ORCID 0000-0001-6389-170X
Diego GerminiCNRS UMR9018, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.ORCID 0000-0002-6157-1929
Amangeldy K BissenbaevDepartment of Molecular Biology and Genetics, Faculty of Biology and Biotechnology, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0001-7837-8685
Yana R MusinovaKoltzov Institute of Developmental Biology of Russian Academy of Sciences, 119991 Moscow, Russia.
Evgeny V ShevalBelozersky Institute of Physicochemical Biology, Moscow State University, 119899 Moscow, Russia.
Yegor VassetzkyCNRS UMR9018, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.ORCID 0000-0003-3101-7043
Svetlana DokudovskayaCNRS UMR9018, Institut Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.ORCID 0000-0001-6032-622X
Centre National de la Recherche Scientifique · FRLomonosov Moscow State University · RUAl-Farabi Kazakh National University · KZ

Funding

INSERM Enviburkitt
6 · The paper itself

Abstract

HIV-1 infects T cells, but the most frequent AIDS-related lymphomas are of B-cell origin. Molecular mechanisms of HIV-1-induced oncogenic transformation of B cells remain largely unknown. HIV-1 Tat protein may participate in this process by penetrating and regulating gene expression in B cells. Both immune and cancer cells can reprogram communications between extracellular signals and intracellular signaling pathways via the Akt/mTORC1 pathway, which plays a key role in the cellular response to various stimuli including viral infection. Here, we investigated the role of HIV-1 Tat on the modulation of the Akt/mTORC1 pathway in B cells. We found that HIV-1 Tat activated the Akt/mTORC1 signaling pathway; this leads to aberrant activation of activation-induced cytidine deaminase (

Indexed as

DNA DamageGene Expression RegulationAICDA (Activation-Induced Cytidine Deaminase)B-LymphocytesCells, CulturedCytidine DeaminaseHumansMechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mybReactive Oxygen SpeciesRepressor Proteinstat Gene Products, Human Immunodeficiency VirusTranscriptional ActivationAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseE2F8 protein, humanMechanistic Target of Rapamycin Complex 1MYB protein, humanProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mybReactive Oxygen SpeciesRepressor Proteinstat Gene Products, Human Immunodeficiency VirusAICDAAkt/mTORC1 pathwayB cellsHIV-1Tat

Identifiers

PMID33557396
PMCPMC7915967
OpenAlexW3126709808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.